Introduction: Emphasizing and evaluating different prognostic factors including the age, size of the tumor, type of surgery, capsular infiltration and administration of adjuvant chemotherapy, which may affect the disease free survival (DFS) and overall survival (OS) in patients with malignant Granulosa cell tumors (MGCTs). . Follow -up reached up to 116 months (3-116 mo.) with a median of 72 months. Prognostic factors as the age, size of the tumor, type of surgery, capsular infiltration and administration of adjuvant chemotherapy with number of cycles in correlation with DFS and OS were statistically analyzed to detect any significant correlation.
Results:
The median age was 44 years. The median tumor size was 12 cm. The median DFS was 41.9 months. The median OS was 45.0 months. The disease free survival (DFS) was not significantly affected by the size of the tumor (<10 cm/ ≥10 cm) nor the type of surgery 
Introduction
Granulosa cell tumors (GCT) of the ovary are classified as sex-cord stromal tumors and their occurrence is rare, represent about 5% of all ovarian tumors. Two distinct types of GCTs: adult (AGCT) and juvenile (JGCT) [1] [2] [3] .
These tumors differ from other ovarian cancers with its hormonal behavior and low grade nature [4] . GCTO grow slowly and can recur late, after primary treatment The reported median age at the diagnosis is about 49 [5] .
Surgery is the primary treatment of GCTs and includes hysterectomy, bilateral adnexectomy, and omentectomy as well as biopsies from peritoneal surfaces. The necessity for lymphadenectomy has varied over the decades and is not currently recommended [6] [7] [8] [9] [10] [11] [12] . The role of adjuvant therapy is unclear, although in advanced-stage disease, platinum-based chemotherapy is nowadays recommended [6, 13, 14] , however, either adjuvant chemotherapy or radiotherapy could not obtain an evidence based consequence [12, 15] . Inspite the generally favorable prognosis of GCTs, 97% survive for 5-years, however poor prognosis up to 66.8% survival after 20 years and 30-35% mortality needing longer follow-up in early stages and for lifelong [7] . Recurrence rates were documented from as low as 5.6% after primary surgical treatment [16] up to 21% with a median time to relapse was 57.6 months (2-166 months) [17] , and the longest reported times to recurrence were 40 years [18] and 25 years [19] . 
Patients and Methods

Statistical Method
Demographic data and survival outcome will be analyzed using SPSS statistical package version 20. Relations between qualitative data will be done using Chi-square test or Fisher's exact test. Moreover, survival analyses will be done using Kaplan Meier's method and Comparison between survival curves will be done using log-rank test. A p-value less than 0.05 will be considered significant.
Results
The The tumor sizes in this study were grouped according to the longest diameter into: Tumor size < 10 cm. ( 
Discussion
Egyptian studies addressing granulosa cell tumors are few with limited number of patients due to the rarity of this type of tumors, requesting further studies to define the proper prognostic factors [9, 20] 
Conclusion
Capsular infiltration is by far the most independent prognostic factor affecting disease free survival (DFS) in patients with malignant granulosa cell tumors and to a lesser extent overall survival (OS), Tumor size ≥10 cm is nearly affecting OS but not DFS. A Multi-institutional study with larger sample size and longer follow-up is needed to re-evaluate our results.
